T1	Participants 15 105	acial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening
T2	Participants 179 269	blacks and Hispanics, are generally underrepresented among participants in clinical trials
T3	Participants 1686 1729	recruit racial/ ethnic minorities into PLCO
